Isorhamnetin Downregulates MMP2 and MMP9 to Inhibit Development of Rheumatoid Arthritis through SRC/ERK/CREB Pathway
Crossref DOI link: https://doi.org/10.1007/s11655-023-3753-6
Published Online: 2024-01-12
Published Print: 2024-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Xiao-rong
Li, Shuo-fu
Mei, Wen-ya
Liu, Xiang-dan
Zhou, Ri-bao
Text and Data Mining valid from 2024-01-12
Version of Record valid from 2024-01-12
Article History
Accepted: 29 June 2023
First Online: 12 January 2024
Conflict of Interest
: The authors have no conflict of interest to declare.